163 related articles for article (PubMed ID: 29960067)
1. LncRNA TUG1 affects cell viability by regulating glycolysis in osteosarcoma cells.
Han X; Yang Y; Sun Y; Qin L; Yang Y
Gene; 2018 Oct; 674():87-92. PubMed ID: 29960067
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA PVT1 promotes glycolysis and tumor progression by regulating miR-497/HK2 axis in osteosarcoma.
Song J; Wu X; Liu F; Li M; Sun Y; Wang Y; Wang C; Zhu K; Jia X; Wang B; Ma X
Biochem Biophys Res Commun; 2017 Aug; 490(2):217-224. PubMed ID: 28602700
[TBL] [Abstract][Full Text] [Related]
3. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
Li G; Liu K; Du X
Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA TUG1 contributes to tumorigenesis of human osteosarcoma by sponging miR-9-5p and regulating POU2F1 expression.
Xie CH; Cao YM; Huang Y; Shi QW; Guo JH; Fan ZW; Li JG; Chen BW; Wu BY
Tumour Biol; 2016 Nov; 37(11):15031-15041. PubMed ID: 27658774
[TBL] [Abstract][Full Text] [Related]
5. LncRNA-SARCC sensitizes osteosarcoma to cisplatin through the miR-143-mediated glycolysis inhibition by targeting Hexokinase 2.
Wen JF; Jiang YQ; Li C; Dai XK; Wu T; Yin WZ
Cancer Biomark; 2020; 28(2):231-246. PubMed ID: 32508321
[TBL] [Abstract][Full Text] [Related]
6. TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p.
Cao J; Han X; Qi X; Jin X; Li X
Int J Oncol; 2017 Oct; 51(4):1115-1123. PubMed ID: 28902349
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of Long Noncoding RNA TUG1 Inhibits the Proliferation and Cellular Invasion of Osteosarcoma Cells by Sponging miR-153.
Wang H; Yu Y; Fan S; Luo L
Oncol Res; 2018 Jun; 26(5):665-673. PubMed ID: 28411362
[TBL] [Abstract][Full Text] [Related]
8. Polydatin inhibits proliferation and promotes apoptosis of doxorubicin-resistant osteosarcoma through LncRNA TUG1 mediated suppression of Akt signaling.
Hu T; Fei Z; Su H; Xie R; Chen L
Toxicol Appl Pharmacol; 2019 May; 371():55-62. PubMed ID: 30974157
[TBL] [Abstract][Full Text] [Related]
9. miR‑185 regulates the growth of osteosarcoma cells via targeting Hexokinase 2.
Liu C; Cai L; Li H
Mol Med Rep; 2019 Sep; 20(3):2774-2782. PubMed ID: 31524259
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA Taurine upregulated gene 1 promotes osteosarcoma cell metastasis by mediating HIF-1α via miR-143-5p.
Yu X; Hu L; Li S; Shen J; Wang D; Xu R; Yang H
Cell Death Dis; 2019 Mar; 10(4):280. PubMed ID: 30911001
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma.
Ma B; Li M; Zhang L; Huang M; Lei JB; Fu GH; Liu CX; Lai QW; Chen QQ; Wang YL
Tumour Biol; 2016 Apr; 37(4):4445-55. PubMed ID: 26499949
[TBL] [Abstract][Full Text] [Related]
12. PI3K/Akt signaling mediated Hexokinase-2 expression inhibits cell apoptosis and promotes tumor growth in pediatric osteosarcoma.
Zhuo B; Li Y; Li Z; Qin H; Sun Q; Zhang F; Shen Y; Shi Y; Wang R
Biochem Biophys Res Commun; 2015 Aug; 464(2):401-6. PubMed ID: 26116768
[TBL] [Abstract][Full Text] [Related]
13. LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis.
Xie C; Chen B; Wu B; Guo J; Cao Y
Biomed Pharmacother; 2018 Jan; 97():1645-1653. PubMed ID: 29793327
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of long non-coding RNA TUG1 inhibits osteosarcoma cell proliferation and promotes apoptosis.
Zhang Q; Geng PL; Yin P; Wang XL; Jia JP; Yao J
Asian Pac J Cancer Prev; 2013; 14(4):2311-5. PubMed ID: 23725133
[TBL] [Abstract][Full Text] [Related]
15. Anticancer potential of TUG1 knockdown in cisplatin-resistant osteosarcoma through inhibition of MET/Akt signalling.
Zhou Q; Hu T; Xu Y
J Drug Target; 2020 Feb; 28(2):204-211. PubMed ID: 31305159
[TBL] [Abstract][Full Text] [Related]
16. [miR-125b suppresses the aerobic glycolysis of osteosarcoma HOS cells by downregulating the expression of hexokinase-2].
Wu Y; He H; Wu B; Wen J; Guo Z; Luo Y; Cao G
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Oct; 33(10):1365-1370. PubMed ID: 29169422
[TBL] [Abstract][Full Text] [Related]
17. Role of taurine upregulated gene 1 as a predictor of poor outcome in osteosarcoma.
Wang Q; Chen Q
J Cancer Res Ther; 2018 Jun; 14(Supplement):S405-S409. PubMed ID: 29970697
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of LncRNA-UCA1 suppresses chemoresistance of pediatric AML by inhibiting glycolysis through the microRNA-125a/hexokinase 2 pathway.
Zhang Y; Liu Y; Xu X
J Cell Biochem; 2018 Jul; 119(7):6296-6308. PubMed ID: 29663500
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA EPIC1 inhibits viability and invasion of osteosarcoma cells by promoting MEF2D ubiquitylation.
Zhao W; Zhang D; Qin P; Zhang J; Cui X; Gao J; Wang J; Li J
Int J Biol Macromol; 2019 May; 128():566-573. PubMed ID: 30703420
[TBL] [Abstract][Full Text] [Related]
20. LncRNA WWOX‑AS1 inhibits the proliferation, migration and invasion of osteosarcoma cells.
Qu G; Ma Z; Tong W; Yang J
Mol Med Rep; 2018 Jul; 18(1):779-788. PubMed ID: 29845204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
